Pymedix
Pymedix is a medical technology company specializing in fully automated machine perception technologies to advance radiotherapy. Their flagship product, Autofuse, is the first and only automatic 3D deformable image registration software designed to improve accuracy and speed in radiation treatment planning. By leveraging neuroscience-inspired 3D vision algorithms, Pymedix enhances personalized cancer treatment and optimizes workflow for radiation oncologists, dosimetrists, and physicists. The company combines expertise in medicine, engineering, and research to maintain a leading position in personalized medicine and big data applications in oncology.
Pymedix
Pymedix is a medical technology company specializing in fully automated machine perception technologies to advance radiotherapy. Their flagship product, Autofuse, is the first and only automatic 3D deformable image registration software designed to improve accuracy and speed in radiation treatment planning. By leveraging neuroscience-inspired 3D vision algorithms, Pymedix enhances personalized cancer treatment and optimizes workflow for radiation oncologists, dosimetrists, and physicists. The company combines expertise in medicine, engineering, and research to maintain a leading position in personalized medicine and big data applications in oncology.
TL;DR
Headquarters: Chicago, Illinois, United States
Founded: 2018
Flagship product: Autofuse (3D deformable image registration software)
Employees (approx.): 5
Last disclosed funding: Pre-Seed (Feb 12, 2020)
Company Overview
Problem Domain
Radiation oncology imaging and radiotherapy treatment planning
Founded
2018
Industry
Medical technology / Medical AI
Funding Track Record
290000.00